CATX
Perspective Therapeutics, Inc.
$4.18-0.09 (-2.11%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Perspective Therapeutics, Inc. (CATX) is a publicly traded company with 8 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 8 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 12 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | Martinez Maria E | Director | Award | 50,000 | $5.35 | $267,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Morich Frank | Director | Award | 50,000 | $5.35 | $267,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Williamson Robert F Iii | Director | Award | 50,000 | $5.35 | $267,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Henson Heidi | Director | Award | 50,000 | $5.35 | $267,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Woods Lori A | Director | Award | 50,000 | $5.35 | $267,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Spoor Johan M. | CEO | Award | 735,000 | $5.35 | $3,932,250 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Hunt Jonathan Robert | CAO | Award | 90,000 | $5.35 | $481,500 | N/A | N/A |
| 2026-03-04 | 2026-03-02 | Puhlmann Markus | CMO | Award | 150,000 | $5.35 | $802,500 | N/A | N/A |
| 2025-11-17 | 2025-11-13 | Hunt Jonathan Robert | CAO | Purchase | 11,000 | $2.03 | $22,297 | +4.6% | +31.7% |
| 2025-11-14 | 2025-11-12 | Williamson Robert F Iii | Director | Purchase | 9,498 | $2.10 | $19,946 | +9.5% | +27.1% |
CATX
Director
Award
$267.5K
Williamson Robert F Iii50,000 shares @ $5.35
Filed 2026-03-04Trade 2026-03-02
CATX
Director
Purchase
$19.9K
Williamson Robert F Iii9,498 shares @ $2.10
Filed 2025-11-14Trade 2025-11-12
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.